The influence of hepatitis B virus (HBV) genotypes in the natural history of the disease and its response to antiviral treatment have been addressed in many studies. In Brazil, studies on HBV genotype circulation have been restricted to specific population groups and states. Here, we have conducted a nationwide multicentre study with an unprecedented sample size representing all Brazilian regions in an effort to better understand the viral variants of HBV circulating among chronic carriers. Seven HBV genotypes were found circulating in Brazil. Overall, HBV/A was the most prevalent, identified in 589 (58.7 %) samples, followed by HBV/D (23.4 %) and HBV/F (11.3 %). Genotypes E, G, C and B were found in a minor proportion. The distribution of the genotypes differed markedly from the north to the south of the country. While HBV/A was the most prevalent in the North (71.6 %) and Northeast (65.0 %) regions, HBV/D was found in 78.9 % of the specimens analysed in the South region. HBV/F was the second most prevalent genotype in the Northeast region (23.5 %). It was detected in low proportions (7 to 10 %) in the North, Central-West and Southeast regions, and in only one sample in the South region. HBV/E was detected in all regions except in the South, while monoinfection with HBV/G was found countrywide, with the exception of Central-West states. Our sampling covered 24 of the 26 Brazilian states and the Federal District and is the first report of genotype distribution in seven states. This nationwide study provides the most complete overview of HBV genotype distribution in Brazil to date and reflects the origin and plurality of the Brazilian population.
INTRODUCTION
Chronic hepatitis B still represents a significant global public health problem despite the availability of an effective preventive vaccine against the aetiologic agent of the infection, hepatitis B virus (HBV). The World Health Organization (WHO) estimates that more than 240 million people worldwide are chronic carriers of HBV, an infection that represents an increasing risk of liver complications such as cirrhosis and hepatocellular carcinoma [1, 2] .
HBV features a unique replication strategy in which the production of new genomic DNA molecules is preceded by an RNA intermediate synthesized by reverse transcription. The lack of proofreading activity during this replication step yields high substitution rates in the genome, conferring an increased genetic variability to HBV than would be expected for a DNA virus [3] .
Based on this genetic variability, HBV has been classified into eight genotypes (A-H) by divergences of more than 7.5 % in the entire genome sequences within each genetic group [4, 5] . More recently, two additional genotypes (I and J) were tentatively proposed [6, 7] . Although recent studies have shown that the distribution pattern of HBV genotypes is changing, especially in regions of the world with elevated migratory waves, in general these ten genetic groups have distinct geographical distributions [8, 9] . Genotype A has a worldwide distribution but is primarily found in Northern Europe, North America and sub-Saharan Africa. Genotypes B and C are preferably found in East and Southeast Asia, and Oceania. A worldwide distribution is also a characteristic of the genotype D strains, with higher prevalence being reported in European, Middle Eastern and Mediterranean countries. Genotype E is endemic to West Africa and is rarely found outside Africa, a pattern similar to that observed for genotypes F and H, whose geographic distributions are almost restricted to Central and South America. Genotype G is not restricted to a specific location and has been reported in samples from the USA, Mexico, France, Germany, Turkey, Brazil and Japan. The newly designated genotypes I and J were only detected in individuals from Vietnam and Japan, respectively [4, 10] .
Brazil is a federal republic composed of a Federal District and 26 states that are distributed within five geographic regions (North, Northeast, Central-West, Southeast and South), each presenting socio-demographic, economic and cultural particularities. One of the main characteristics of the population as a whole is its aetiological plurality, with great miscegenation among the native population, European colonizers, descendants of African slaves and more recent immigration of individuals from European, Asian and African countries. Regarding the prevalence of HBV infection, different rates can be observed throughout the country. While Brazil is considered a country with low to intermediate prevalence of HBsAg carriers (less than 1 %) [11, 12] , there are some areas of high endemicity for HBV infection like the Amazon basin and villages located in the South and Southeast regions [13] .
Although studies regarding HBV genotype circulation in Brazil have been published, most are restricted to a particular state and to specific population groups. In addition, HBV genotype distribution is unknown in seven of the 26 Brazilian states, namely Amap a, Espírito Santo, Cear a, Minas Gerais, Paraíba, Sergipe and Roraima. This multicentre study included samples from 24 of the 26 Brazilian states and the Federal District, including samples from capitals and from hundreds of cities countrywide, being the most comprehensive and representative overview of the circulation of HBV genotypes among chronic carriers in Brazil to date.
RESULTS
Sampling, demographic characteristics and overall HBV genotype distribution Among the 1004 samples included in the study, the proportion of samples from each Brazilian geographical region included in this nationwide overview of HBV genotype distribution roughly reproduces the proportion of the population living in the corresponding regions, with the exception of the South region, which was slightly under-represented in the total sample size. Regarding all 26 Brazilian states, only two states, Piauí and Rio Grande do Norte, both located in the Northeast region, had no samples included in the study. In relation to gender, of the 915 samples with available information, 58.7 % were from men. The mean age of the patients was 43.4±13.7 years with more than 50 % of the samples with available information being from individuals between 30 and 50 years old. Viral load was available for 919 samples and the majority (37.2 %) of them had values between 3.3 and 4.3 log, a range that requires continuous monitoring of the individual in order to evaluate the necessity of starting antiviral treatment. The distributions of demographic and virological characteristics according to geographic region of the study population are listed in Table 1. A total of 1004 serum samples were genotyped by INNOLiPA assay (n=835) and by direct nucleotide sequencing (n=169). Seven HBV genotypes (A-G) were found circulating in Brazil. Overall, HBV genotype A was the most prevalent, being identified in 589 (58.7 %) samples, followed by genotypes D (235; 23.4 %) and F (114; 11.3 %). Genotypes E, G, C and B were found in minor proportions in 18, 13, 9 and 1 sample(s), respectively. Among the samples genotyped by INNO-LiPA assay, infection with more than one genotype (mixed infection) was detected in 25 samples (2.5 %).
Statistical analyses to evaluate the relationship between the most prevalent genotypes (A, D and F) and gender, age groups and viral load did not reveal any significant relationship.
A distinct genotype distribution was found in the different states of the country (Fig. 1) . The distribution of HBV genotypes A, D and F in the five Brazilian geographic regions indicated that HBV/A was the most prevalent in the North (151/211; 71.6 %), Northeast (141/217; 65.0 %), CentralWest (50/87; 57.5 %) and Southeast (232/394; 58.9 %) regions (Table 1 ). An exception to this higher prevalence of genotype A was observed in the South region, where genotype D was found in nearly 80 % of the specimens analysed. HBV/D was the second most prevalent in the North, Central-West and Southeast regions, accounting for 14.2, 27.6 and 22.6 %, respectively, of total sampling in these regions. In relation to genotype F, a similarly low proportion (7 to 11 %) was found in samples from the North, Central-West and Southeast regions. This genotype was found in only one sample from the South region and had a high proportion (23.5 %) in the Northeast region, being the second-most prevalent after genotype A.
A detailed distribution of the genotypes found in each state is presented in Table 2 . The regional distribution of HBV genotypes per state indicated that differences in genotype frequency could be remarkable between states within the same geographic region. In the North region, HBV/A was the most prevalent in all states (Fig. S1 , available in the online Supplementary Material), achieving proportions greater than 78 % in samples from Par a, Amazonas and Tocantins. Unlike other states, Amap a showed a high proportion of genotype D (40 %) and had a single case of monoinfection with genotype G. Genotype F was the second most common in Amazonas, Par a, Rondônia and Roraima.
Two chronic carriers infected with genotype E were identified in Amazonas and Rondônia.
A high predominance of genotype A could be observed in all Northeast states, with the exception of Cear a (Fig. S2 ). This genotype was found exclusively among samples from Alagoas and had substantial frequencies in Sergipe (91.7 %), Bahia (84.1 %) and Pernambuco (74.2 %). Genotype D was not frequently found in the Northeast region as a whole, having a considerable proportion only in Maranhão, infecting 36.7 % of the analysed samples. Genotype F was the major genotype circulating in Cear a (52.6 %) and found in 35.5 % of the samples from Paraíba. HBV genotypes C, E and G, not commonly detected in Brazil, were found in Cear a. Bahia had one case of genotype E infection and an HBV/G monoinfection was observed in Paraíba.
Regarding the Central-West region, in the Federal District and in Goi as, the great majority of samples was classified as HBV/A (71.4 and 86.2 %, respectively) while genotype D prevailed in Mato Grosso do Sul (54.5 %). Frequencies under 15 % were observed for HBV/F in the states from this region and only one infection with genotype E was found in Mato Grosso do Sul (Fig. S3) .
In São Paulo, Brazil's most populated state, seven HBV genotypes (A-G) were detected circulating among chronic carriers. Genotypes A, D and F were most frequently observed (46.1, 30.4 and 7.4 %, respectively). São Paulo had 10 cases of HBV/E, eight monoinfections with HBV/G, seven HBV/C and one HBV/B. In Rio de Janeiro and Minas Gerais, genotype A represented nearly 80 % of the analysed samples and Espírito Santo had the greatest proportion of genotype D (33.3 %) among the states of the Southeast region (Fig. S4 ).
In the South region, a high predominance of genotype D strains among the study population was observed (Fig. S5 ). This genotype was very frequent in all three states, representing 74.3 % of the samples from Paran a, 79.1 % from Rio Grande do Sul and 88.2 % from Santa Catarina. HBV/A prevalence ranged from 11.8 to 17.1 % and HBV/F was found in only one sample from Paran a. In Rio Grande do Sul, one sample characterized as a monoinfection with genotype G was detected.
Confirmation of INNO-LiPA results by direct sequencing and genotype-specific PCR assay
In order to confirm the reliability of HBV genotyping by LiPA, 85 samples genotyped using this methodology, including randomly selected samples and those characterized as genotypes not commonly reported in Brazil (genotypes B, C, E and H), were submitted to direct nucleotide sequencing to compare the results. Comparison between both methodologies indicated a 97.6 % (83/85) concordance 
*Data considering available information for each category. †Log. [17] . This discrepancy, which is more than that associated with a shift in the circulation of HBV strains in Brazil during the decade separating sampling, may reflect differences between the In addition to genotypes A, D and F, another four HBV genotypes were found to be circulating in Brazil in minor proportions. To our knowledge, only one previously published work reported the co-circulation of the main eight HBV genotypes in a single country. Osiowy et al. [19] identified, in a study with acute and chronic hepatitis B cases, HBV genotypes A-I circulating in Canada, a country that shares some similarities with Brazil, such as the continental dimensions of its territory and having immigrants of different nationalities [19] . It is interesting to note that, in our study, genotypes A-G were detected in a single state, São Paulo. It is Brazil's most populated state, has a large number of immigrant communities and is one of the main destinations of internal migratory flux in Brazil. The circulation of genotypes B, C and E is usually restricted to specific geographic regions (HBV/B and HBV/C in Eastern Asia and HBV/E in West Africa) [20] and there are only a few reports of its circulation in Brazil [15, 18, 21] . It is likely that these 'foreign' genotypes reflect the origin of the immigrants or the country where a Brazilian citizen acquired the virus, reinforcing the concept that HBV genotype might act as a valuable tool in the surveillance of viral spread. Regarding HBV genotype G, the least common throughout the world and usually found in co-infection with another genotype, our findings indicated the presence of 13 samples in monoinfection, a condition rarely reported in studies worldwide [22] [23] [24] , which deserves further investigation to confirm the single genotype character of the infection.
Analysing the results of genotype distribution focusing on states per geographic region, previous studies carried out with samples from the North region reported a predominance of HBV/A in Acre, Amazonas, Par a and Tocantins [25] [26] [27] [28] , which was corroborated by our findings. A higher frequency of genotype D (45 %) compared to other states in the North region was observed in a study with HBsAg-positive pregnant women in Acre [29] . Here, although in a lower prevalence likely due to differences in the studied population, we also found a higher proportion of HBV/D samples in this state (21 % [32, 34] . Interestingly, samples from Maranhão available in our study were genotyped by direct sequencing and demonstrated being closely related with D4 reference sequences, presumably related to the strong influence of African descendants in Maranhão's population.
Most of the studies conducted in the states in the CentralWest region have been targeted to specific population groups such as injecting drug users [35] , men who have sex with men [36] , waste collectors [37] and HIV-positive patients [38, 39] , impairing an appropriate comparison with our sampling. Despite this, these previous studies reported a greater incidence of HBV/A in Goi as and HBV/D in Mato Grosso do Sul, which was confirmed here. Genotype distribution in Federal District, geographically located inside the territory of Goi as, followed the findings from this state. The Central-West region is considered an area of late occupation in Brazil that received migratory fluxes from the South, Southeast and Northeast regions after the federal capital of Brazil moved to Brasília in 1960. Our results indicated that Goi as and the Federal District had a genotype distribution similar to that observed in the Southeast region while the higher frequency of HBV/D found in Mato Grosso do Sul might be related to its geographical proximity to the states in the South region.
The circulation of three main genotypes, A, D and F, has been demonstrated in the Southeast region since the first report on HBsAg subtype diversity in 1987 [40] . The higher prevalence of HBV/A, followed by HBV/D and HBV/F in smaller proportions, has been confirmed in several studies since then [14, 17, [41] [42] [43] [44] [45] [46] [47] . Here, we show for the first time the distribution of genotypes in two other states in the Southeast region, Minas Gerais and Espírito Santo. The main presence of the three genotypes was observed, with a significantly higher proportion of genotype D found in Espírito Santo when compared to Rio de Janeiro (P<0.005). This difference might be explained by the historical process of territorial occupation in Espírito Santo, where a large migratory contingent, mainly composed of Italians, has settled in the state since the 19th century [48] . In São Paulo, our findings indicated the circulation of HBV genotypes typically found in other parts of the world, as is the case for genotypes B and C in Asia and genotype E in West Africa. The identification of 12.4 % of samples with genotypes rarely found in Brazil agrees with the cosmopolitan character of São Paulo, a state that is home to diverse foreign communities of different ethnicities.
The relationship between HBV genotype and the ancestral origin of an infected individual is very evident when analysing samples from states in the South region. All three states were the destination of a large contingent of European immigrants, coming especially from Italy and Germany in the mid-20th century. This ancestral background is likely responsible for the very high prevalence of HBV/D found in Paran a (74.3 %), Rio Grande do Sul (79.1 %) and Santa Catarina (88.2 %), which is corroborated in the studies available in the literature [15, [49] [50] [51] . A genetic study based on mtDNA heritage also confirmed a greater influence of European origins in the population from the South region [52] .
The method chosen for this study was the commercial assay 'INNO-LiPA HBV Genotyping' which has automated hybridization, scanner reading and strip interpretation, and standardization and reproducibility that allow the execution of tests in different laboratories around the country. This methodology is considered relatively simple, rapid and reliable, and has been used in other large-scale studies [19, 53] . One of the advantages highlighted by the commercial line probe assay manufacturer is the greater sensitivity of the test when compared to direct sequencing, which makes it capable of identifying minority viral populations. However, a limitation of methods based on reverse hybridization is that polymorphisms in the genomic region amplified for the hybridization with the immobilized probes may lead to unspecific binding and consequent misinterpretation of the result. Although previous studies had reported that INNOLiPA was sensitive in detecting infection with more than one HBV genotype (mixed infection), especially genotypes A/B, A/C, A/G and B/C co-infection [53] [54] [55] , our results showed an unexpectedly high proportion (8. [56, 57] . In terms of genotype circulation, however, the assumption that mixed infections D/G and F/G were methodological artefacts would not greatly affect the overall genotype distribution.
This large-scale study had some limitations. Information about the ethnic background of the studied individuals would have been useful to establish a relation with the different genotypes found. Furthermore, demographic data was not available for all the samples and the cross-sectional nature of our study meant that the sampling included multiple scenarios regarding the stage of disease chronicity and management. The presence of untreated individuals along with patients under antiviral therapy for years or starting a rescue treatment with a new drug prevented the application of statistical analysis aiming to identify a relationship between certain genotypes and the outcome of disease.
The influence of the different HBV genotypes in the natural history of the disease and the response to antiviral treatment remains unclear [10] . Nonetheless, there is increasing evidence that HBV genotypes may be associated with a higher rate of progression to chronic infection and hepatocellular carcinoma, spontaneous HBeAg seroconversion, mutations in the precore and/or in basal core promoter, and response to interferon-based therapy [9] . Moreover, the genetic variability of HBV expressed in the different genotypes and its distinct distribution around the world and in relation to ethnic background make genotype classification a useful tool in epidemiological and transmission studies.
In this nationwide, multicentre study, our findings provide the most complete overview of HBV genotype distribution in Brazil to date, spanning virtually all Brazilian states and hundreds of cities countrywide. These data might contribute to molecular epidemiological surveillance of strains circulating in the country, assisting and supporting the strategic actions of the Ministry of Health to monitor and control viral dissemination. Genotyping by line probe assay A total of 835 extracted viral DNA samples were submitted to nested PCR amplification using specific biotinylated primers directed to the HBsAg genomic region supplied by the INNO-LiPA HBV Genotyping Kit. The PCR cycle conditions were based on the manufacturer's protocol and amplicons were visualized in a 2 % agarose gel for certification of proper product length. PCR product denaturation, hybridization to genotype-specific probes immobilized on membrane strips and posterior processing of the strips in a streptavidin-based chromogenic reaction were performed using the automated workstation AutoBlot3000H (MedTec, North Carolina, USA). Reading and interpretation of strips were also automated using a scanner and LiRAS report software (Fujirebio Europe, Gent, Belgium). All participating laboratories processed the samples using this equipment and following the same protocol.
METHODS

Study population
Genotyping by direct nucleotide sequencing and phylogenetic analysis A total of 169 extracted HBV DNA samples were submitted to PCR amplification and nucleotide sequencing of a genomic region containing portions of both ORFs P and S with primers and thermal cycling profiles as described by Mallory et al. [58] . The generated PCR products of approximately 1 kb were purified using the Wizard SV Gel and PCR Clean-Up System (Promega, Madison, USA) and prepared for sequencing using the BigDye Terminator 3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, USA) along with internal sequencing primers as described by Mallory et al. [58] . Sequencing products were electrophoresed on an ABI 3500 Genetic Analyzer (Applied Biosystems).
HBV genotyping was performed by phylogenetic analysis of the DNA sequences determined in this study compared with a multiple sequence alignment of HBV sequences representing all known genotypes available in GenBank. Phylogenetic analysis was carried out using the maximumlikelihood method (bootstrap resampling test with 1000 replicates) in MEGA version 6.0 software [59] under the model of nucleotide substitution GTR+G+I, which was selected as the best-fit model by the jModeltest program [60] .
Confirmation of INNO-LiPA results by direct sequencing and genotype-specific PCR assay
To confirm the reliability of genotyping results of the INNO-LiPA HBV Genotyping Kit, 10.2 % (85/835) of the samples were randomly selected for direct nucleotide sequencing. In addition to this randomly selected percentage of samples, those characterized by INNO-LiPA as genotypes B, C, E and H, rarely reported in Brazil, were also submitted to direct sequencing, upon availability of the specimen. Also, a semi-nested PCR assay using HBV genotype G-specific primers was performed as previously described [61] to confirm the high proportion of mixed infection with genotype G indicated by the INNO-LiPA assay results, especially mixed infection of genotypes D/G and F/G, an unusual profile of infection.
Statistical analysis
Univariate analyses were used to describe the distribution of hepatitis B genotypes and categorical variables gender, age group and viral load range. Differences in genotype prevalence in each region and its comparison with previously reported data were also accessed by univariate analysis.
Fisher's exact test and Pearson's chi-squared test were used to test the significance level of associations, which was assessed at the 0.05 probability level. All analyses were conducted using the software Epi Info version 7.1 (Centers for Disease Control and Prevention, Atlanta, USA). 
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